|
Vesicular Glutamate
Transporters (VGLUT1/BNPI, VGLUT2/DNPI, EAT-4) and Sialin Antibodies
A distinct step in inter cellular
communication involves termination of synaptic transmission via the removal
of neurotransmitters by specialized transporters. There are 2 classes of
transporters: plasma membrane and vesicular. The plasma membrane
transporters (GABA, norepinephrine, dopamine, glycine, etc) use an
electrochemical gradient of Na+ generated by an Na-K+-ATPase and Cl- may
also be co-transported. Vesicular transporters (monoamines, serotonin,
dopamine, norepinephrine, epinephrine, and histamine) utilized the H+
electrochemical gradient generated by a vacuolar ATP-dependent H+ pump
(V-ATPase) located on vesicular plasma membrane. Most recently, vesicular
type transporters for glutamate, termed VGLUTs
(VGLUT1/BNPI, VGLUT2/DNPI, EAT-4), have been
cloned and characterized that are related to phosphate transporters.
Although neurons exhibit Na-dependent Pi transport, the biological role of
Pi uptake is not clear. Inorganic phosphate is essential for various
cellular metabolic functions and signal transport. Proximal tubules in the
kidney reabsorb Pi in the glomeruli by the action of a group of phosphate
transporters (Type 1-NaPi related, type 2-NaPi-2 related, and type 3-viral
receptor-related. These receptor show weak (~20% identity) between various
subtypes.
A distinct type of brain specific
Na+-dependent phosphate (Pi) transporter (BNPI),
originally characterized as a plasma membrane transporter has been localized
in a subset of glutamatergic neurons (amygdala,cereberal cortex, and
hippocmaplus) and identified as VGLUT1 (rat and
human 560 aa; ~60 kDa, ~30% homology with type-1 Pi-transporters).
Interestingly, a sequence induced by subtoxic levels of NMDA in cerebelar
granules also belongs to this family of transporters. BNPI/VGLUT1 is
expression is restricted to the brain, where it is predominantly located in
synaptic vesicles. VGLUT1 shows strong sequence homology to
EAT-4, a C. elegans protein that appears to
have specific presynaptioc role in glutamtergic
transmission. Loss of function mutations in EAT-4 affects multiple
glutamregic neurotransmission pathways. EAT4 encodes a protein of 563 aa
(~48% identity with BNPI and ~30% identity with known NaPi-transporters
found in mammalian kidney). Like BNPI, EAT-4 is also expressed in
glutamatergic neurons.
A novel transporter
VGLUT2/DNPI (Differentiation-assocaited Na-Pi cotransporter, ~75%
homology with VGLUT1; human VGLUT2; human/rat/mouse 582 aa) has also been
implicated in vesicular glutamate transport. It is expressed in only a
subset of neurons. It is also localized to synaptic vesicles, at synapses
exhibiting classical excitatory features. VGLUT2 mRNA is found in brain
regions that lack VGLUT1.
Sialic acid storage disease (SASD) are
autosomal recessive neurdegenerative disorders that may present as a severa
infantile form (ISSD) or a slowly progressive adult form (Salla disease)
prevalent in Finland. The patients exccrete large amounts of free sialic
acid in urine. A H+/anionic sugar symporter mechanism for sialinc acid and
glucoronic acid is impaired in lysosomal membranes from Sall and ISSD. A new
gene, termed Sialin (SLC17A5; human 495 aa,
chromosome 6q14-q15) belonging to the family of anion/cation symporters
(ACS) has been found to be mutated in sialic acid storage disease. Sialin is
predicted to contain up to 12 TM domains with N and C-termini located in the
cytoplasm. Sialin has 37%, 34%, and 16% sequence identity with BNPI/VGLUT1,
NPT1 (Napi-I), and E. coli hexuronate (EcHex) transporter, respectively.
Sialin is found to be expressed in many human tissues.
ADI has produced highly specific
rabbit-antibodies to
VGLLUT1, VGLUT2, EAT4, and Sialin using
peptide sequences specific to each protein. These antibodies should be
useful in studying specific transporters.
|
Items |
Antigen peptide location |
Antibody Host |
**Expected Ab
Crossreactivity |
Antiserum
Cat #
(100 ul) |
Aff. Pure IgG
Cat #
(100 ug) |
* Control Peptide
Cat#
(100 ug |
VGLUT1/BNPI
Ab # 1 |
R, 19 aa ~CT |
Ch |
m, r, h |
VGLUT11-S |
VGLUT11-A |
VGLUT11-P |
VGLUT1/BNPI
Ab # 2 |
H, 18 aa ~NT |
Rb |
m, r, h |
VGLUT12-S |
VGLUT12-A |
VGLUT12-P |
VGLUT2/DNPI
Ab # 1 |
H, 18 aa ~NT |
Rb |
m, r, h |
VGLUT21-S |
VGLUT21-A |
VGLUT21-P |
VGLUT2/DNPI
Ab # 2 |
R, 20 aa ~CT |
Rb |
R, M, H |
VGLUT22-S |
VGLUT22-A |
VGLUT22-P |
| EAT4 |
CE, 18 aa ~NT |
Rb |
CE |
EAT45-S |
EAT45-A |
EAT45-P |
| Sialin |
h, 17 aa
~EC1 |
Rb |
H (m, r?) |
SIAL11-S |
SIAL11-A |
SIAL11-P |
M= Mouse; R=Rat; H=Human; Ha=Hamster; Rb=Rabbit; B=Bovine; CE=C.
elegans;Ch=chicken; CT= near C-terminus; NT=near N-terminus;
EC1=extracellular domain;
** Expected antibody crossreactivity information is mostly based upon
high (>70%) sequence conservation of antigenic/control peptides in various
species. When antibody crossreactivity has actually been experimentally
confirmed in various species, it will be mentioned in the appropriate data
sheets.
"Neat Antisera" are the unpurified
antiserum and it is suitable for ELISA and Western.
"Affinity pure"
IgG may be more suitable for immunohistochemical (IHC) applications
and to reduce background in most immunological applications including ELISA
and Western.
"Control peptides" can not be used for
Western as they are very short peptides. They are intended for ELISA or
antibody blocking studies to establish antibody specificity.
All Products are for in vitro research use only.
rev 20601
Key words: Vesicular Glutamate
Transporters (VGLUT1/BNPI, VGLUT2/DNPI, EAT-4) and Sialin Antibodie, brain
specific Na+-dependent phosphate (Pi) transporter (BNPI) antibodies,
VGLUT2/DNPI (Differentiation-assocaited Na-Pi cotransporter antibodies,
sialin antibodies, Vesicular Glutamate Transporters (VGLUT1/BNPI,
VGLUT2/DNPI, EAT-4) and Sialin Antibodie, brain specific Na+-dependent
phosphate (Pi) transporter (BNPI) antibodies, VGLUT2/DNPI
(Differentiation-assocaited Na-Pi cotransporter antibodies, sialin
antibodies, Vesicular Glutamate Transporters (VGLUT1/BNPI, VGLUT2/DNPI,
EAT-4) and Sialin Antibodie, brain specific Na+-dependent phosphate (Pi)
transporter (BNPI) antibodies, VGLUT2/DNPI (Differentiation-assocaited Na-Pi
cotransporter antibodies, sialin antibodies, Vesicular Glutamate
Transporters (VGLUT1/BNPI, VGLUT2/DNPI, EAT-4) and Sialin Antibodie, brain
specific Na+-dependent phosphate (Pi) transporter (BNPI) antibodies,
VGLUT2/DNPI (Differentiation-assocaited Na-Pi cotransporter antibodies,
sialin antibodies, Vesicular Glutamate Transporters (VGLUT1/BNPI,
VGLUT2/DNPI, EAT-4) and Sialin Antibodie, brain specific Na+-dependent
phosphate (Pi) transporter (BNPI) antibodies, VGLUT2/DNPI
(Differentiation-assocaited Na-Pi cotransporter antibodies, sialin
antibodies, Vesicular Glutamate Transporters (VGLUT1/BNPI, VGLUT2/DNPI,
EAT-4) and Sialin Antibodie, brain specific Na+-dependent phosphate
|